drugset

drugset / Trial / NCT00194935

Weekly Topotecan Therapy in Patients With Ovarian Cancer

NCT00194935 ↗

Phase 2 Terminated 32 enrolled Weill Medical College of Cornell University

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out the safety and feasibility of weekly topotecan consolidation therapy in patients with ovarian cancer.

Timeline

Start: 2003-02
Primary completion: —
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Topotecan	Small molecule	4 mg/m2	—

Indications